Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Carcinoma, Renal Cell 35Kidney Neoplasms 8Neoplasms 6Neoplasm Metastasis 6Carcinoma, Non-Small-Cell Lung 6Melanoma 5Carcinoma, Hepatocellular 5Colorectal Neoplasms 4Recurrence 3Lung Neoplasms 3Glioblastoma 3Carcinoma 3Thyroid Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Skin Neoplasms 2Sarcoma 2Pheochromocytoma 2Paraganglioma 2Liver Neoplasms 2Endometrial Neoplasms 2Clear-cell metastatic renal cell carcinoma 2Carcinoma, Adenoid Cystic 2cT2a N0NxM0 Renal Tumor 1Uveal Melanoma 1Urinary Bladder Neoplasms 1Solitary Fibrous Tumors 1Sarcoma, Alveolar Soft Part 1Salivary Gland Neoplasms 1Relapsed Pediatric Solid Tumor 1Radiation Therapy 1

Interventions

Bevacizumab 3Everolimus 2tozuleristide 1neratinib 1icotinib 1brigatinib 1Sirolimus 1Mn-PyC3A 1Losartan 1Lapatinib 1Fluoresceins 1Fluorescein 1Endostatins 1Axitinib 1Aspirin 1AZD 6244 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Neuroma, Acoustic × Axitinib × Clear all
NCT02129647 2021-12-01

Study of Axitinib in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas

NYU Langone Health

Phase 2 Completed
13 enrolled 7 charts
CNS

Neuroma, Acoustic, Neurofibromatosis 2

Data powered by HemOnc (CC BY 4.0) Colophon âš¡